Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment

NCT05793450 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: IBI362

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.